Endocrinology, Vol 125, 267-274, Copyright © 1989 by Endocrine Society

ARTICLES

Multiple cytokines stimulate hepatic lipid synthesis in vivo

KR Feingold, M Soued, MK Serio, AH Moser, CA Dinarello and C Grunfeld
Department of Medicine, University of California, San Francisco.

We have previously shown that administration of tumor necrosis factor- alpha (TNF alpha) to intact rats results in an acute (within 60-120 min) stimulation of hepatic fatty acid synthesis, which persists for an extended period. Hepatic cholesterol synthesis is also stimulated by 16- 17 h after TNF alpha treatment. We now demonstrate, using intact mice, that stimulation of hepatic lipid synthesis is not solely the property of the cytokine TNF alpha. Incorporation of 3H2O into fatty acids in the liver was increased 60-120 min and 16-17 h after the administration of TNF beta, interleukin-1 (IL-1), and interferon-alpha (IFN alpha). TNF alpha, IL-1, and IFN alpha all rapidly stimulate hepatic fatty acid synthesis (within 0-30 min), with the peak occurring at 60-120 min. The half-maximal doses of TNF alpha (200 ng) and IL-1 (20 ng) that stimulate hepatic fatty acid synthesis are similar to those that induce fever, a well recognized biological effect of these cytokines. Additionally, hepatic cholesterol synthesis was increased 16-17 h after TNF beta, IL-1, and IFN gamma treatment. The present study demonstrates that multiple cytokines from different cell types which act through different receptors can stimulate hepatic fatty acid and cholesterol synthesis. Previous studies have shown that multiple cytokines can inhibit the synthesis and storage of fat in cultured adipose cells. Taken together, these data indicate that multiple signals to perturb lipid metabolism may be produced as a consequence of an immunological or inflammatory response.

This article has been cited by other articles:

				K. F. Tacer, D. Kuzman, M. Seliskar, D. Pompon, and D. Rozman TNF-{alpha} interferes with lipid homeostasis and activates acute and proatherogenic processes Physiol Genomics, October 19, 2007; 31(2): 216 - 227. [Abstract] [Full Text] [PDF]

				M. J. Delano and L. L. Moldawer The Origins of Cachexia in Acute and Chronic Inflammatory Diseases Nutr Clin Pract, February 1, 2006; 21(1): 68 - 81. [Abstract] [Full Text] [PDF]

				C. P Earnest, A. N Jordan, M. Safir, E. Weaver, and T. S Church Cholesterol-lowering effects of bovine serum immunoglobulin in participants with mild hypercholesterolemia Am. J. Clinical Nutrition, April 1, 2005; 81(4): 792 - 798. [Abstract] [Full Text] [PDF]

				P. Crenn, B. Rakotoanbinina, J.-J. Raynaud, F. Thuillier, B. Messing, and J.-C. Melchior Hyperphagia Contributes to the Normal Body Composition and Protein-Energy Balance in HIV-Infected Asymptomatic Men J. Nutr., September 1, 2004; 134(9): 2301 - 2306. [Abstract] [Full Text] [PDF]

				W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]

				F. Picard, D. Arsenijevic, D. Richard, and Y. Deshaies Responses of Adipose and Muscle Lipoprotein Lipase to Chronic Infection and Subsequent Acute Lipopolysaccharide Challenge Clin. Vaccine Immunol., July 1, 2002; 9(4): 771 - 776. [Abstract] [Full Text] [PDF]

				A. A. IONESCU, L. S. NIXON, S. LUZIO, V. LEWIS-JENKINS, W. D. EVANS, M. D. STONE, D. R. OWENS, P. A. ROUTLEDGE, and D. J. SHALE Pulmonary Function, Body Composition, and Protein Catabolism in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 495 - 500. [Abstract] [Full Text] [PDF]

				D. P. Kotler Cachexia Ann Intern Med, October 17, 2000; 133(8): 622 - 634. [Abstract] [Full Text] [PDF]

				M. J. Bennett, D. Hauton, D. G. Hole, and R. D. Evans Utilization of very low density lipoprotein by rat heart: the effect of endotoxin Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E802 - E810. [Abstract] [Full Text] [PDF]

				S.-S. Yeh and M. W Schuster Geriatric cachexia: the role of cytokines Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197. [Abstract] [Full Text] [PDF]

				R. A. Memon, W. M. Holleran, Y. Uchida, A. H. Moser, S. Ichikawa, Y. Hirabayashi, C. Grunfeld, and K. R. Feingold Regulation of Glycosphingolipid Metabolism in Liver during the Acute Phase Response J. Biol. Chem., July 9, 1999; 274(28): 19707 - 19713. [Abstract] [Full Text] [PDF]

				C. Grunfeld, W. Doerrler, M. Pang, P. Jensen, K. H. Weisgraber, and K. R. Feingold Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3734 - 3740. [Abstract] [Full Text] [PDF]

				J. Juvonen, H.-M. Surcel, J. Satta, A.-M. Teppo, A. Bloigu, H. Syrjala, J. Airaksinen, M. Leinonen, P. Saikku, and T. Juvonen Elevated Circulating Levels of Inflammatory Cytokines in Patients With Abdominal Aortic Aneurysm Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2843 - 2847. [Abstract] [Full Text]

				J.-M. Lacorte, E. Ktistaki, A. Beigneux, V. I. Zannis, J. Chambaz, and I. Talianidis Activation of CAAT Enhancer-binding Protein delta  (C/EBPdelta ) by Interleukin-1 Negatively Influences Apolipoprotein C-III Expression J. Biol. Chem., September 19, 1997; 272(38): 23578 - 23584. [Abstract] [Full Text] [PDF]